Kristina Wang

Kristina Wang is a highly accomplished professional with a diverse educational background and a wealth of experience in the fields of immunology, business, finance, and engineering.

She holds a Master of Science in Immunology from Harvard Medical School, a Master of Business Administration from Harvard Business School, a Bachelor of Science in Economics and Finance from the University of Pennsylvania, and a Bachelor of Science in Chemical and Biomolecular Engineering from the University of Pennsylvania.

Kristina has held key roles in several prestigious organizations, including Apertura Gene Therapy where she was the Corp Dev, Founding COO; Denali Therapeutics where she managed Corp Dev and Portfolio Management; F-Prime Capital Partners where she served as an Investor; Merrill Lynch where she worked as an Investment Banking Analyst; and Formation 8 where she started as a Summer Analyst.